Cargando…

Exploration of the shared genes and signaling pathways between lung adenocarcinoma and idiopathic pulmonary fibrosis

BACKGROUND: Idiopathic pulmonary fibrosis (IPF), a type of interstitial lung disease (ILD), is a chronic disease with an unknown etiology. The occurrence of lung cancer (LC) is one of the main causes of death in patients with IPF. However, the pathogenesis driving these malignant transformations rem...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Houqiang, Wang, Wenmiao, Huang, Zhanghao, Zhang, Peng, Liu, Lei, Sha, Xinyu, Wang, Silin, Zhou, You Lang, Shi, Jiahai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10323588/ https://www.ncbi.nlm.nih.gov/pubmed/37426132 http://dx.doi.org/10.21037/jtd-22-1522

Ejemplares similares

Identification of lysosomal genes associated with prognosis in lung adenocarcinoma
por: Li, Houqiang, et al.
Publicado: (2023)

Identification of a polycomb group-related gene signature for predicting prognosis and immunotherapy efficacy in lung adenocarcinoma
por: Liu, Lei, et al.
Publicado: (2023)

Analysis of prognostic model based on immunotherapy related genes in lung adenocarcinoma
por: Zhang, Peng, et al.
Publicado: (2022)

Histone acetylation modification regulator-mediated tumor microenvironment infiltration characteristics and prognostic model of lung adenocarcinoma patients
por: Wang, Wenmiao, et al.
Publicado: (2022)

Identification of potential biomarkers associated with CD4(+) T cell infiltration in myocardial ischemia-reperfusion injury using bioinformation analysis
por: Wang, Wenmiao, et al.
Publicado: (2023)

PRKCB is relevant to prognosis of lung adenocarcinoma through methylation and immune infiltration
por: Wang, Jinjie, et al.
Publicado: (2022)

Sustainably released nanoparticle-based rhynchophylline limits pulmonary fibrosis by inhibiting the TEK-PI3K/AKT signaling pathway
por: Wang, Shuo, et al.
Publicado: (2023)

Loss of IL-34 Expression Indicates Poor Prognosis in Patients With Lung Adenocarcinoma
por: Wang, Zhendong, et al.
Publicado: (2021)

Low expression of IL6R predicts poor prognosis for lung adenocarcinoma
por: Sun, Gaofeng, et al.
Publicado: (2021)

Durable response to nivolumab in a lung adenocarcinoma patient with idiopathic pulmonary fibrosis
por: Ide, Maako, et al.
Publicado: (2018)

Identification of a potential bioinformatics-based biomarker in keloids and its correlation with immune infiltration
por: Li, Zihan, et al.
Publicado: (2023)

Characteristic of molecular subtypes in lung adenocarcinoma based on m6A RNA methylation modification and immune microenvironment
por: Zhou, Hao, et al.
Publicado: (2021)

Idiopathic Pulmonary Fibrosis Complicated by Adenocarcinoma and Organizing Pneumonia
por: Inutsuka, Yu, et al.
Publicado: (2022)

COVID-19 lung disease shares driver AT2 cytopathic features with Idiopathic pulmonary fibrosis
por: Sinha, Saptarshi, et al.
Publicado: (2022)

Paired analysis of tumor mutation burden for lung adenocarcinoma and associated idiopathic pulmonary fibrosis
por: Yoneshima, Yasuto, et al.
Publicado: (2021)

Extracellular matrix proteins produced by stromal cells in idiopathic pulmonary fibrosis and lung adenocarcinoma
por: Kreus, Mervi, et al.
Publicado: (2021)

Lung Transplantation in Idiopathic Pulmonary Fibrosis
por: Laporta Hernandez, Rosalía, et al.
Publicado: (2018)

Lung Transplantation for Idiopathic Pulmonary Fibrosis
por: Lamas, Daniela J., et al.
Publicado: (2013)

Physiology of the lung in idiopathic pulmonary fibrosis
por: Plantier, Laurent, et al.
Publicado: (2018)

Exploring Animal Models That Resemble Idiopathic Pulmonary Fibrosis
por: Tashiro, Jun, et al.
Publicado: (2017)

Autophagy in Idiopathic Pulmonary Fibrosis: Predisposition of the Aging Lung to Fibrosis?
por: Zmijewski, Jaroslaw W., et al.
Publicado: (2022)

Alterations to the Lung Microbiome in Idiopathic Pulmonary Fibrosis Patients
por: Tong, Xunliang, et al.
Publicado: (2019)

Shared genetic etiology between idiopathic pulmonary fibrosis and COVID-19 severity
por: Fadista, João, et al.
Publicado: (2021)

Caveolin-1: a critical regulator of lung fibrosis in idiopathic pulmonary fibrosis
por: Wang, Xiao Mei, et al.
Publicado: (2006)

FGF2 and FGFR2 in patients with idiopathic pulmonary fibrosis and lung cancer
por: Li, Li, et al.
Publicado: (2018)

Effects of Nintedanib on Quantitative Lung Fibrosis Score in Idiopathic Pulmonary Fibrosis
por: Lancaster, Lisa, et al.
Publicado: (2020)

Macrophages: friend or foe in idiopathic pulmonary fibrosis?
por: Zhang, Lei, et al.
Publicado: (2018)

ADCY9 functions as a novel cancer suppressor gene in lung adenocarcinoma
por: Tang, Yijie, et al.
Publicado: (2023)

Shared genetic risk factors: implications for treatment of idiopathic pulmonary fibrosis and systemic hypertension
por: Parcesepe, Gina, et al.
Publicado: (2023)

The reliability of lung ultrasound in assessment of idiopathic pulmonary fibrosis
por: Manolescu, Diana, et al.
Publicado: (2018)

Idiopathic Pulmonary Fibrosis and Lung Transplantation: When it is Feasible
por: Balestro, Elisabetta, et al.
Publicado: (2019)

Lung function trajectories in patients with idiopathic pulmonary fibrosis
por: Neely, Megan L, et al.
Publicado: (2023)

Invadosome Formation by Lung Fibroblasts in Idiopathic Pulmonary Fibrosis
por: Lebel, Mégane, et al.
Publicado: (2022)

Idiopathic pulmonary fibrosis
por: Meltzer, Eric B, et al.
Publicado: (2008)

Idiopathic Pulmonary Fibrosis
por: Lynch, Joseph P., et al.
Publicado: (2011)

Lung Microbiome in Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases
por: Amati, Francesco, et al.
Publicado: (2022)

Nintedanib prevented fibrosis progression and lung cancer growth in idiopathic pulmonary fibrosis
por: Fukunaga, Kentaro, et al.
Publicado: (2018)

Idiopathic Pulmonary Fibrosis and Post-COVID-19 Lung Fibrosis: Links and Risks
por: Patrucco, Filippo, et al.
Publicado: (2023)

Identification of the shared genes and immune signatures between systemic lupus erythematosus and idiopathic pulmonary fibrosis
por: Liao, Sheng, et al.
Publicado: (2023)

Trade-offs in aging lung diseases: a review on shared but opposite genetic risk variants in idiopathic pulmonary fibrosis, lung cancer and chronic obstructive pulmonary disease
por: van Moorsel, Coline H.M.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_enfdmpit6a531ebn80khsnv8sa